8.00

1.11% -0.09

Cogent Biosciences Inc (COGT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$8.09

Aprire:

$8.18

Volume 24 ore:

938.05K

Relative Volume:

0.63

Capitalizzazione di mercato:

$883.69M

Reddito:

Utile/perdita netta:

$-242.30M

Rapporto P/E:

-3.2258

EPS:

-2.48

Flusso di cassa netto:

$-192.10M

1 W Prestazione:

-0.37%

1M Prestazione:

-2.44%

6M Prestazione:

-21.88%

1 anno Prestazione:

-6.54%

Intervallo 1D:

$7.89

$8.23

Intervallo di 1 settimana:

$7.88

$8.285

Portata 52W:

$5.73

$12.61

Cogent Biosciences Inc Stock (COGT) Company Profile

Nome

Cogent Biosciences Inc

Settore

Healthcare (1169)

Industria

Biotechnology (678)

Telefono

617-945-5576

Indirizzo

275 WYMAN STREET, WALTHAM

Dipendente

164

Cinguettio

Prossima data di guadagno

2024-10-31

Ultimi documenti SEC

COGT's Discussions on Twitter

Confronta COGT con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
COGT Cogent Biosciences Inc	8.00	883.69M	0	-242.30M	-192.10M	-2.48
VRTX Vertex Pharmaceuticals Inc	484.24	124.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	700.33	76.56B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	644.48	39.16B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	250.59	32.44B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	120.01	28.77B	3.30B	-501.07M	1.03B	-2.1146

Cogent Biosciences Inc Stock (COGT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-12-11	Downgrade	Needham	Buy → Hold
2024-02-26	Downgrade	Robert W. Baird	Outperform → Neutral
2024-02-08	Iniziato	Citigroup	Buy
2023-12-11	Downgrade	Wedbush	Outperform → Neutral
2023-12-08	Iniziato	JP Morgan	Overweight
2023-04-28	Iniziato	Robert W. Baird	Outperform
2023-03-27	Ripresa	H.C. Wainwright	Buy
2022-12-14	Iniziato	Needham	Buy
2022-06-28	Iniziato	Guggenheim	Buy
2021-10-11	Iniziato	H.C. Wainwright	Buy
2021-06-09	Ripresa	Jefferies	Buy
2020-12-23	Iniziato	Piper Sandler	Overweight
2020-10-14	Iniziato	Ladenburg Thalmann	Buy

Mostra tutto

Cogent Biosciences Inc Borsa (COGT) Ultime notizie

02:47 AM

Brokerages Set Cogent Biosciences, Inc. (NASDAQ:COGT) Target Price at $14.33 - MarketBeat

Feb 11, 2025

Cogent Biosciences (NASDAQ:COGT) Trading Down 5.9% – What’s Next? - Defense World

Feb 11, 2025

Investing in Cogent Biosciences Inc (COGT) might be an excellent idea, but the stock is currently overvalued/undervalued – US Post News - US Post News

Feb 11, 2025

Is Cogent Biosciences (COGT) Outperforming Other Medical Stocks This Year? - Nasdaq

Feb 11, 2025

Cogent Biosciences (NASDAQ:COGT) Sees Strong Trading VolumeWhat's Next? - MarketBeat

Feb 11, 2025

FY2025 Earnings Estimate for COGT Issued By Leerink Partnrs - Defense World

Feb 11, 2025

Cogent Biosciences, Inc. (NASDAQ:COGT) Receives $14.33 Consensus PT from Brokerages - Defense World

Feb 11, 2025

Cogent Biosciences Announces Bezuclastinib Poster in - GlobeNewswire

Feb 11, 2025

Feb 10, 2025

Cogent Biosciences Announces Bezuclastinib Poster in NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 2025 AAAAI Annual Meeting - The Manila Times

Feb 10, 2025

Cogent Biosciences to Present Long-Term Efficacy Results of Bezuclastinib at AAAAI Annual Meeting 2025 - Nasdaq

Feb 10, 2025

Cogent's NonAdvSM Treatment Shows Long-Term Patient BenefitsKey Data Coming at AAAAI 2025 - StockTitan

Feb 10, 2025

Feb 09, 2025

One Cogent Biosciences Insider Raised Stake By 2,085% In Previous Year - Simply Wall St

Feb 09, 2025

Feb 08, 2025

Analysts Issue Forecasts for COGT Q1 Earnings - Defense World

Feb 08, 2025

Feb 07, 2025